NovoCure Ltd
Current role
NVCR
Nicolas Leupin, M.D., Ph.D., MBA
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Nicolas Leupin, M.D., Ph.D., MBA
NovoCure Ltd reported in an 8-K filed January 4, 2024 that Nicolas Leupin, M.D., Ph.D., MBA was appointed Chief Medical Officer.
“Novocure (NASDAQ: NVCR) today announced the appointment of Nicolas Leupin, M.D., Ph.D., MBA to the role of Chief Medical Officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
NovoCure Ltd (NVCR)
SEC 8-K
Current2024-01-04–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at NovoCure Ltd
Other people whose current roles at this company are on record from its filings.
- Asaf Danziger CEO, Board Member
- David Hung CEO, Board Member
- Frank Leonard CEO, Board Member
- William Vernon CEO, Board Member
- Kinyip Gabriel Leung Chairman, Board Member
- William Doyle Chairman, Board Member
- Christoph Brackmann CFO
- Jeryl Hilleman CFO, Board Member
- Kristin Stafford CFO, Chief Accounting Officer, Board Member
- Mukund Paravasthu COO
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.